コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 to reliably assess radiographic features of hip osteoarthritis.
2 ociation of the calmodulin 1 gene CALM1 with hip osteoarthritis.
3 may be associated with an increased risk of hip osteoarthritis.
4 osteoarthritis is more common than knee and hip osteoarthritis.
5 involved in the development of hip shape and hip osteoarthritis.
6 ation for advancing research of hip pain and hip osteoarthritis.
7 lant may be a potential therapy for moderate hip osteoarthritis.
8 eatment option to add to BCT for people with hip osteoarthritis.
9 se these to assess causal relationships with hip osteoarthritis.
10 dence supporting use of physical therapy for hip osteoarthritis.
12 ation of the asporin gene ASPN with knee and hip osteoarthritis and an association of the calmodulin
13 ents 50 years of age or older who had severe hip osteoarthritis and an indication for surgery, total
15 ter covid-19.199 adults aged >=40 years with hip osteoarthritis and at least moderate pain: 67 were r
16 g medical costs for functionally significant hip osteoarthritis and for custodial care were derived f
19 inical scenarios-one on surgery referral for hip osteoarthritis and one on opioid prescribing for bac
20 associated with dependency due to worsening hip osteoarthritis and that the procedure increases QALE
24 were adult TRICARE enrollees diagnosed with hip osteoarthritis between March 1, 2018, and March 30,
25 MR analyses suggest hip shape may not cause hip osteoarthritis but is implicated in hip fractures.
26 py (ERT) against the development of knee and hip osteoarthritis, but a potential mechanism for this e
27 lacement is routinely recommended for severe hip osteoarthritis, but data from randomized trials are
28 thways for signals underpinning the knee and hip osteoarthritis comorbidities with type 2 diabetes, r
30 deep learning model for grading radiographic hip osteoarthritis features on radiographs and compare i
32 significant sex-specific effect for asthma, hip osteoarthritis, gout, coronary heart disease and typ
33 studies in individuals with painful knee and hip osteoarthritis have revealed that NGF inhibitors sub
35 ere was no causal effect between any HSM and hip osteoarthritis, however there was evidence that HSM2
37 f women with hip osteoarthritis, the risk of hip osteoarthritis increased twofold with high levels of
38 n Ontario and McMaster Universities Knee and Hip Osteoarthritis Index (WOMAC) and the Australian/Cana
39 lyzing four phenotypes: knee osteoarthritis, hip osteoarthritis, knee and/or hip osteoarthritis, and
42 s were also associated (P < 2.5 x 10-4) with hip osteoarthritis (n = 26) and hip fracture (n = 4).
48 The groin pain experienced by patients with hip osteoarthritis (OA) is often accompanied by areas of
50 dies have reported the prevalence of primary hip osteoarthritis (OA), little has been reported on inc
52 Hip shape is an important determinant of hip osteoarthritis (OA), which occurs more commonly in w
55 graphic progression were assessed in knee or hip osteoarthritis patients (n = 271) who had 2 radiogra
59 ing pace and reduced back pain but increased hip osteoarthritis risk, whereas narrower birth canals w
60 e functionally significant but not dependent hip osteoarthritis, the model predicts that THA is cost
61 in another case-control study of women with hip osteoarthritis, the risk of hip osteoarthritis incre
62 d to estimate causal effects between HSM and hip osteoarthritis using hip fracture as a positive cont
63 tilization of joint arthroplasty for knee or hip osteoarthritis varies markedly by patient race/ethni
64 hort study included all persons with knee or hip osteoarthritis who participated in structured first-
65 ents in the genetic epidemiology of knee and hip osteoarthritis, with particular emphasis on publishe